GLPwatch
Papers (12034)
Page 179 of 201, ranked by citation count.
- Effect of semaglutide on major cardiovascular events.
- Not Just for Diabetes: The Next Frontier for GLP-1 Agonists.
- Carnitine Deficiency Caused by Salcaprozic Acid Sodium Contained in Oral Semaglutide in a Patient with Multiple Acyl-CoA Dehydrogenase Deficiency.
- A rationally designed 18-amino acid peptide with potential as GLP-1 receptor agonist.
- Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.
- [Possibilities of influencing cardiovascular risk in type 2 diabetes mellitus by antidiabetic treatment Lowering of cardiovascular risk in treatment with liraglutide - Results of the LEADER].
- Sequential Intragastric Balloon Followed By GLP-1 Receptor Agonist Therapy in Obesity: A Comparative Study of 12-Month Weight Loss Outcomes.
- Weight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated Weight Loss.
- [Obesity: novel pharmacological treatments].
- Liraglutide Effect on Weight, Glycated Hemoglobin, and Blood Pressure: A Single-Center Experience in the Eastern Province of Saudi Arabia.
- Current clinical application of incretin therapy for obesity management.
- Postprandiale Hyperglykämien: Rascheres Insulin aspart, einmal wöchentliches Semaglutid.
- Renoprotective effects of dulaglutide, a GLP-1 agonist, involving regulation of epithelial-mesenchymal transition in patients with type 2 diabetes and diabetic kidney disease.
- The role of medicinal chemistry in treating obesity, diabetes and metabolic syndrome.
- Exploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis.
- Effects of iron overload and exenatide on erythrocyte deformability in a rat model.
- [Liraglutide reduces biomarkers and vascular risk in patients with diabetes mellitus type 2].
- The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.
- GLPs Significantly Decrease the Risk of Postoperative Surgical Complications: A TriNetX Retrospective Cohort Study.
- Glucagon-like peptide-1 receptor agonist use and clinical outcomes after posterior cervical spinal fusion for degenerative pathologies: A large cohort retrospective analysis.
- Efficacy and safety of Tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis.
- Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework.
- GLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and clinical evidence.
- Metabolic and Glycemic Effects of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta-Analysis of Randomised Clinical Trials.
- 18 F-FDG PET/CT Five Days Post First Administration of Semaglutide : Side Effects in One Shot.
- Dulaglutide as a Bridging Therapy Before Insulin for Diabetes Following Pancreatectomy on Congenital Hyperinsulinism.
- Benefits of Incretin Therapy on Ovarian Function: A Scientific Literature Review.
- A Review of the Oral Semaglutide in Adults with Overweight or Obesity (OASIS) Trials Evaluating Oral Semaglutide (Wegovy) for Chronic Weight Management in Adults With Overweight or Obesity.
- Weight Loss Medications for Adult Patients With Obesity and Binge Eating-A Systematic Review and Meta-analysis.
- Comparative effectiveness of tirzepatide versus thiazolidinedione in adults with MASLD: a propensity score-matched cohort study.
- Glucagon-Like Peptide-1 Receptor Agonists Across the Heart Failure Spectrum: A Systematic Review and Meta-Analysis.
- GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Translational Perspective on Mechanisms and Clinical Implications.
- Development of an electrochemiluminescence immunoassay for quantitative determination of semaglutide in human serum.
- Use of liraglutide in type 1 diabetes: implications for management.
- Real-world experience of semaglutide 2.4 mg in the US: a retrospective analysis of profiles, satisfaction, and treatment patterns in people with obesity and overweight.
- Generalizability of glucagon-like peptide 1 receptor agonist clinical trial results to product labeling and the real world.
- Comparison of low-dose liraglutide use versus other GLP-1 receptor agonists in patients without type 2 diabetes.
- [Effect and mechanism of liraglutide on the apoptosis of human hepatocellular carcinoma HepG2 cells induced with palmitic acid].
- Retatrutide fact check: Has a man died after taking the unapproved weight loss jab?
- Cagrilintide-semaglutide: a new option for patients with type 2 diabetes.
- Subcutaneous injection of semaglutide causes increased muscle uptake of <sup>18</sup>F-FDG and reduces the imaging quality of PET/CT: a case report.
- Semaglutide Is a New Once-Daily Oral Medication to Treat Type 2 Diabetes.
- Tirzepatide (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus.
- [Conserved W52 led to reduced binding of glucogan-like peptide 1 receptor].
- A Systematic Review and Meta-Analysis Evaluating the Role of GLP-1 Receptor Agonists in Substance Use Disorders.
- Semaglutide showed limited improvements in patients with Alzheimer's disease: Revisiting the evoke and evoke + clinical trials.
- Liraglutide improves cognitive function by reducing amyloid-beta peptide accumulation and inhibiting inflammation in 5 × FAD mice.
- [Not Available].
- [The weight-loss injection : An orthopaedic overview].
- Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes.
- Dynamic structural analysis-based epitope prediction of Exendin-4 in aqueous solution.
- Are Glucagon-Like Peptide 1 Receptor Agonists and Bariatric Surgery the Answer to Childhood Obesity?
- Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.
- Initium novum?
- Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.
- Target-mediated drug disposition modeling of liraglutide in rats: Implications of target engagement for pharmacodynamic predictions.
- Can <i>Carica papaya</i> Serve as an Adjunct to Semaglutide in Mitigating Diabetes-Induced Testicular Injury Through Modulation of Oxidative Stress, Inflammation, Apoptosis, and the miR-34c/miR-155-SIRT1/FOXO1 Axis? An Experimental and Chem-Bio-Informatics Study.
- Prescribed but Not Filled: Patient Factors Related to Semaglutide/Tirzepatide Prescription Fills Among Those With Prescription Orders for Obesity Treatment.
- Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.
- Childhood obesity and cardiac risk in youth: Emerging challenges toward 2050.